| PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives V Asati, DK Mahapatra, SK Bharti European journal of medicinal chemistry 109, 314-341, 2016 | 577 | 2016 |
| Anti-cancer chalcones: Structural and molecular target perspectives DK Mahapatra, SK Bharti, V Asati European journal of medicinal chemistry 98, 69-114, 2015 | 549 | 2015 |
| Synthesis, anti-bacterial and anti-fungal activities of some novel Schiff bases containing 2, 4-disubstituted thiazole ring SK Bharti, G Nath, R Tilak, SK Singh European journal of medicinal chemistry 45 (2), 651-660, 2010 | 453 | 2010 |
| Chalcones and their therapeutic targets for the management of diabetes: Structural and pharmacological perspectives DK Mahapatra, V Asati, SK Bharti European journal of medicinal chemistry 92, 839-865, 2015 | 287 | 2015 |
| Chalcone scaffolds as anti-infective agents: Structural and molecular target perspectives DK Mahapatra, SK Bharti, V Asati European journal of medicinal chemistry 101, 496-524, 2015 | 229 | 2015 |
| Chalcone derivatives: anti-inflammatory potential and molecular targets perspectives DK Mahapatra, SK Bharti, V Asati Current topics in medicinal chemistry 17 (28), 3146-3169, 2017 | 174 | 2017 |
| Thiazolidine-2, 4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents V Asati, DK Mahapatra, SK Bharti European journal of medicinal chemistry 87, 814-833, 2014 | 154 | 2014 |
| Therapeutic potential of chalcones as cardiovascular agents DK Mahapatra, SK Bharti Life Sciences 148, 154-172, 2016 | 149 | 2016 |
| Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications DK Mahapatra, SK Bharti, V Asati, SK Singh European journal of medicinal chemistry 174, 142-158, 2019 | 102 | 2019 |
| Protective effect of Calotropis procera latex extracts on experimentally induced gastric ulcers in rat S Bharti, VD Wahane, VL Kumar Journal of Ethnopharmacology 127 (2), 440-444, 2010 | 88 | 2010 |
| Metal based drugs: current use and future potential SK Bharti, SK Singh Der Pharmacia Lettre 1 (2), 39-51, 2009 | 82 | 2009 |
| PIM kinase inhibitors: Structural and pharmacological perspectives V Asati, DK Mahapatra, SK Bharti European journal of medicinal chemistry 172, 95-108, 2019 | 63 | 2019 |
| An updated patent review of therapeutic applications of chalcone derivatives (2014-present) D Kar Mahapatra, V Asati, SK Bharti Expert opinion on therapeutic patents 29 (5), 385-406, 2019 | 60 | 2019 |
| Handbook of research on medicinal chemistry: innovations and methodologies DK Mahapatra, SK Bharti Taylor & Francis, 2017 | 57 | 2017 |
| K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives V Asati, DK Mahapatra, SK Bharti European journal of medicinal chemistry 125, 299-314, 2017 | 56 | 2017 |
| Synthesis, characterization, DNA cleavage and in vitro antimicrobial activities of copper (II) complexes of Schiff bases containing a 2, 4-disubstituted thiazole SK Bharti, SK Patel, G Nath, R Tilak, SK Singh Transition Metal Chemistry 35, 917-925, 2010 | 56 | 2010 |
| Drug design DK Mahapatra, SK Bharti New Delhi: Tara Publications Private Limited, 2016 | 48 | 2016 |
| MEK inhibitors in oncology: A patent review (2015-Present) DK Mahapatra, V Asati, SK Bharti Expert Opinion on Therapeutic Patents 27 (8), 887-906, 2017 | 45 | 2017 |
| Recent developments in the field of anticancer metallopharmaceuticals SK Bharti, SK Singh International Journal of PharmTech Research 1 (4), 1406-1420, 2009 | 41 | 2009 |
| Design, synthesis and molecular modeling studies of novel thiazolidine-2, 4-dione derivatives as potential anti-cancer agents V Asati, SK Bharti Journal of Molecular Structure 1154, 406-417, 2018 | 38 | 2018 |
